Fetal and Neonatal Heart Monitor Market

Fetal and Neonatal Heart Monitor Market By Product Type (Cardiotocograph, Dopplers, Accessories), By Modality (Tabletop Devices, Portable & Handheld Devices), By End User (Hospitals, Neonatal Clinics, Ambulatory Surgical Centers, Diagnostic Centers), and by Region - Global Market Insights 2023 to 2033

Analysis of Fetal and Neonatal Heart Monitor Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Fetal and Neonatal Heart Monitor Market Outlook (2023 to 2033)

Global demand for fetal and neonatal heart monitors stands at US$ 8.9 billion in 2023 and is predicted to increase at a healthy 5.5% CAGR over the next ten years. By 2033-end, the global fetal and neonatal heart monitor market is thus expected to secure US$ 15.2 billion in revenue.

Fetal and neonatal heart monitors are used to check the heartbeat and heart rate of unborn babies in their mother’s wombs. These monitors are essentially used in gynecology procedures through labor and delivery to monitor the health of the fetus. Increasing focus on fetal health monitoring, rapid advancements in medical diagnostic equipment technologies, and growing awareness regarding preterm births and stillbirths are key factors that are estimated to boost demand for fetal and neonatal heart monitors in the future.

  • The World Health Organization (WHO) estimates around 15 million babies are born preterm every year. The rate of preterm birth around the world ranges from 5% to 18% of babies born. WHO defines preterm birth as babies born before 37 completed weeks of gestation.

The launch of new initiatives to reduce the mortality rate among newborn babies by governments and non-profit organizations is also projected to promote sales of fetal and neonatal heart monitors over the next ten years. The rising number of babies requiring care through neonatal intensive care units (NICUs) is also projected to uplift shipments of fetal and neonatal heart monitors across the forecast period.

Surging popularity of non-invasive and minimally invasive devices is projected to offer new opportunities for fetal and neonatal heart monitor producers over the coming years. However, stringent regulatory mandates and safety regulations are expected to prove to be major challenges that market players will have to overcome in the future.

On the contrary, declining birth rates and evolving preferences of women to have children late or not have children at all are expected to hurt fetal and neonatal heart monitor shipments in the long run. The absence of developed healthcare infrastructure and lack of proper availability of neonatal care are also expected to foil market growth throughout the forecast period.

An exhaustive analysis of growth-altering aspects such as supply chain management, local supply, and other trends has been mentioned in this fetal and neonatal heart monitor market research study by Fact.MR, a market research and competitive intelligence provider.

Report Attributes


Market Size (2023)

US$ 8.9 Billion

Projected Market Value (2033F)

US$ 15.2 Billion

Global Market Growth Rate (2023 to 2033)

5.5% CAGR

Leading Regional Market (2023)

Asia Pacific

Key Companies Profiled

  • GE Healthcare
  • Becton, Dickinson and Company
  • Analogic Corporation
  • Siemens Healthlineers
  • Masimo Corporation
  • Medtronic Plc
  • Drägerwerk AG & Co. KGaA
  • Natus
  • Spacelabs Healthcare
  • Phoenix Medical Systems
  • Getinge AB

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Will Start-ups be Able to Transform the Future of Fetal Care?

“New Companies Focusing on Innovation and Capital Raising to Advance Neonatal Care”

New fetal and neonatal heart monitor suppliers are focusing on integrating advanced technologies such as artificial intelligence (AI), machine learning, etc. to improve the capability of their neonatal devices.

  • Janitri, a new start-up based in India, is focusing on providing medical-grade fetal monitoring solutions and maternal monitoring solutions to improve maternal mortality rates and reduce stillbirths in the Indian population. The company provides a patch made of plastic and silicone called Keyar Patch, which can be stuck to the belly of the pregnant woman and allows remote monitoring of maternal heart rate, fetal heart rate, fetal movements, etc.

New fetal monitor manufacturers are also raising new finance to fund their research and development activity and advance their business scope around the world.

  • In February 2023, Raydiant Oximetry Inc., a company focusing on maternal and fetal health monitoring, announced the start of its Series B financing round with an investment from the March of Dimes Innovation Fund. The company recently demonstrated its innovative LUMERAHTM technology with a 95% sensitivity and 85.5% specificity for fetal distress successfully in a clinical study. This successful demonstration was expected to help the company to achieve its target of US$ 25 million in its Series B funding round.

More insights about new developments by fetal and neonatal heart monitor start-ups and how they are affecting product standards and pricing trends have been extensively discussed in this latest Fact.MR research study.

Fetal And Neonatal Heart Monitor Market Forecast by Fact.MR

Country-wise Insights

Why Should Fetal and Neonatal Heart Monitor Suppliers Focus on the United States?

“Increasing Awareness Regarding Fetal Health to Boost Market Growth”

The developed healthcare infrastructure of the United States creates an opportune scenario for fetal and neonatal heart monitor providers. Rising awareness regarding neonatal health monitoring and growing spending on fetal care among pregnant women in the country are also projected to uplift fetal and neonatal heart monitor sales in the future. High investments in medical research and development activities in the United States are also anticipated to favor market growth in the long term.

Declining birth rates and a rising number of preterm births are factors that could promote the adoption of neonatal and fetal care devices in the country going forward.

  • As per statistics listed on the Centers for Disease Control and Prevention (CDC) website, preterm birth affected 1 out of every 10 babies born in the United States and the preterm birth rate was 10.5% in 2021, up from 10.1% recorded in 2020.

Favorable reimbursement policies and the presence of good medical insurance coverage for neonatal care in the United States are projected to promote demand for fetal and neonatal heart monitors over the coming years through 2033.

How Will Fetal and Neonatal Heart Monitor Sales Fare in Japan and South Korea?

“Declining Birth Rates to Affect Shipments of Fetal Heart Monitors”

Japan and South Korea have been witnessing a drop in birth rates over the past few years and the problem has been worsening in recent years as these countries hit record lows. The rapid aging of the population of these countries is another prospect that contributes to the plummeting birth rates among other factors.

  • South Korea has the lowest fertility rate of all the countries in the world with 0.9 children per woman, as per the statistics listed on the World Population Review website.

Rapid urbanization and modernization in Japan and South Korea have also majorly contributed to declining birth rates in the countries and hence are projected to hurt demand for fetal and neonatal heart monitors in the future. However, governments in both of the aforementioned countries are focusing on solving this population issue by launching new initiatives to help uplift birthrates and bring about some fundamental changes to society to alleviate the stress on the economy that has been caused by the rising geriatric population.

Will European Countries Be Remunerative Markets for Fetal and Neonatal Heart Monitor Vendors?

“Increasing Prevalence of Diabetes & Obesity to Bolster Demand for Neonatal Heart Monitors”

The number of premature/preterm births has been increasing in European countries in recent years and is projected to rise further over the coming years. This can be ascribed to the rising prevalence of obesity and diabetes among women, which in turn is boosting demand for fetal and neonatal care in countries such as Germany, Italy, the United Kingdom, etc.

  • As per an article listed on the European Commission website, around 500,000 premature births are recorded in Europe every year and the numbers are expected to increase in the future.

High incidence of obesity, diabetes, and other health issues in women result in complications for unborn babies and also put their life at risk, which necessitates the use of neonatal monitoring and diagnostic equipment to keep them safe. Rising awareness regarding fetal health, a growing number of stillbirths and preterm births, and increasing healthcare expenditure are other factors that are predicted to augment sales of fetal and neonatal heart monitors in European countries over the next ten years.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Where are Fetal and Neonatal Heart Monitor Sales Slated to Rise Rapidly?

“Hospitals Projected to Account for Significant Market Share”

Based on end user, the fetal and neonatal heart monitor market is segmented into hospitals, neonatal clinics, ambulatory surgical centers, and diagnostic centers.

Hospitals account for the majority of the fetal and neonatal heart monitor demand at present and are anticipated to maintain a similar stance across the forecast period as well. The rising rate of hospitalization and the installation of new neonatal care units in hospitals are key factors that are projected to bolster sales of fetal heart monitors and other neonatal care devices such as neonatal ventilators, neonatal dialysis equipment, etc. over the next ten years.

Rising awareness regarding pregnancy and fetal care in developing economies is also predicted to contribute to high shipments of fetal and neonatal heart monitors in hospitals through 2033.

Competitive Landscape

Prime fetal and neonatal heart monitor suppliers are focusing on launching new and advanced products to expand their business potential and gain a competitive edge in the global landscape.

  • CONTEC Medical Systems Co. Ltd., a company focusing on the manufacturing and distribution of medical devices, announced the launch of the CMS1700B Color Doppler Ultrasonic Diagnostic System in March 2021.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments of Fetal and Neonatal Heart Monitor Industry Research

  • By Product Type :

    • Cardiotocograph
    • Dopplers
    • Accessories
  • By Modality :

    • Tabletop Devices
    • Portable & Handheld Devices
  • By End User :

    • Hospitals
    • Neonatal Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

- FAQs -

The global fetal and neonatal heart monitor market is valued at US$ 8.9 billion in 2023.

Fetal and neonatal heart monitor sales are forecasted to reach US$ 15.2 billion by 2033-end.

Over the next ten years, worldwide sales of fetal and neonatal heart monitors are projected to rise at 5.5% CAGR.

Product type, modality, end user, and region are the key segments covered in this Fact.MR research survey.

Analogic Corporation, Siemens Healthlineers, Masimo Corporation, and Medtronic Plc. are key manufacturers of fetal and neonatal heart monitors.

Fetal and Neonatal Heart Monitor Market

Schedule a Call

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy